Literature DB >> 15879400

What can mendelian randomisation tell us about modifiable behavioural and environmental exposures?

George Davey Smith1, Shah Ebrahim.   

Abstract

Mesh:

Year:  2005        PMID: 15879400      PMCID: PMC557238          DOI: 10.1136/bmj.330.7499.1076

Source DB:  PubMed          Journal:  BMJ        ISSN: 0959-8138


× No keyword cloud information.
  19 in total

1.  Mendelian randomisation: a new spin or real progress?

Authors:  Julian Little; Muin J Khoury
Journal:  Lancet       Date:  2003-09-20       Impact factor: 79.321

2.  Those confounded vitamins: what can we learn from the differences between observational versus randomised trial evidence?

Authors:  Debbie A Lawlor; George Davey Smith; Devi Kundu; K Richard Bruckdorfer; Shah Ebrahim
Journal:  Lancet       Date:  2004-05-22       Impact factor: 79.321

3.  Commentary: the hormone replacement-coronary heart disease conundrum: is this the death of observational epidemiology?

Authors:  Debbie A Lawlor; George Davey Smith; Shah Ebrahim
Journal:  Int J Epidemiol       Date:  2004-05-27       Impact factor: 7.196

4.  Commentary: Mendelian randomization and gene-environment interaction.

Authors:  Paul Brennan
Journal:  Int J Epidemiol       Date:  2004-02       Impact factor: 7.196

5.  Commentary: Katan's remarkable foresight: genes and causality 18 years on.

Authors:  Bernard Keavney
Journal:  Int J Epidemiol       Date:  2004-02       Impact factor: 7.196

Review 6.  Mendelian randomization: prospects, potentials, and limitations.

Authors:  George Davey Smith; Shah Ebrahim
Journal:  Int J Epidemiol       Date:  2004-02       Impact factor: 7.196

7.  Commentary: development of Mendelian randomization: from hypothesis test to 'Mendelian deconfounding'.

Authors:  Martin D Tobin; Cosetta Minelli; Paul R Burton; John R Thompson
Journal:  Int J Epidemiol       Date:  2004-02       Impact factor: 7.196

Review 8.  Fibrinogen, C-reactive protein and coronary heart disease: does Mendelian randomization suggest the associations are non-causal?

Authors:  G Davey Smith; R Harbord; S Ebrahim
Journal:  QJM       Date:  2004-03

Review 9.  5,10-Methylenetetrahydrofolate reductase gene variants and congenital anomalies: a HuGE review.

Authors:  L D Botto; Q Yang
Journal:  Am J Epidemiol       Date:  2000-05-01       Impact factor: 4.897

10.  Methylenetetrahydrofolate reductase polymorphism (C677T), hyperhomocysteinemia, and risk of ischemic cardiovascular disease and venous thromboembolism: prospective and case-control studies from the Copenhagen City Heart Study.

Authors:  Jeppe Frederiksen; Klaus Juul; Peer Grande; Gorm B Jensen; Torben V Schroeder; Anne Tybjaerg-Hansen; Børge G Nordestgaard
Journal:  Blood       Date:  2004-06-29       Impact factor: 22.113

View more
  145 in total

1.  Two-step epigenetic Mendelian randomization: a strategy for establishing the causal role of epigenetic processes in pathways to disease.

Authors:  Caroline L Relton; George Davey Smith
Journal:  Int J Epidemiol       Date:  2012-02       Impact factor: 7.196

2.  Randomised by (your) god: robust inference from an observational study design.

Authors:  George Davey Smith
Journal:  J Epidemiol Community Health       Date:  2006-05       Impact factor: 3.710

Review 3.  Mendelian randomization: can genetic epidemiology help redress the failures of observational epidemiology?

Authors:  Shah Ebrahim; George Davey Smith
Journal:  Hum Genet       Date:  2007-11-23       Impact factor: 4.132

4.  An evaluation of the genetic-matched pair study design using genome-wide SNP data from the European population.

Authors:  Timothy Tehua Lu; Oscar Lao; Michael Nothnagel; Olaf Junge; Sandra Freitag-Wolf; Amke Caliebe; Miroslava Balascakova; Jaume Bertranpetit; Laurence Albert Bindoff; David Comas; Gunilla Holmlund; Anastasia Kouvatsi; Milan Macek; Isabelle Mollet; Finn Nielsen; Walther Parson; Jukka Palo; Rafal Ploski; Antti Sajantila; Adriano Tagliabracci; Ulrik Gether; Thomas Werge; Fernando Rivadeneira; Albert Hofman; André Gerardus Uitterlinden; Christian Gieger; Heinz-Erich Wichmann; Andreas Ruether; Stefan Schreiber; Christian Becker; Peter Nürnberg; Matthew Roberts Nelson; Manfred Kayser; Michael Krawczak
Journal:  Eur J Hum Genet       Date:  2009-01-21       Impact factor: 4.246

5.  The mathematical limits of genetic prediction for complex chronic disease.

Authors:  Katherine M Keyes; George Davey Smith; Karestan C Koenen; Sandro Galea
Journal:  J Epidemiol Community Health       Date:  2015-02-03       Impact factor: 3.710

Review 6.  Novel biochemical risk factors for type 2 diabetes: pathogenic insights or prediction possibilities?

Authors:  N Sattar; S G Wannamethee; N G Forouhi
Journal:  Diabetologia       Date:  2008-04-08       Impact factor: 10.122

Review 7.  Is chronic fatigue syndrome (CFS/ME) heritable in children, and if so, why does it matter?

Authors:  Esther Crawley; George Davey Smith
Journal:  Arch Dis Child       Date:  2007-09-05       Impact factor: 3.791

8.  Generating large-scale longitudinal data resources for aging research.

Authors:  John Gallacher; Scott M Hofer
Journal:  J Gerontol B Psychol Sci Soc Sci       Date:  2011-07       Impact factor: 4.077

9.  Assessing pleiotropy and mediation in genetic loci associated with chronic obstructive pulmonary disease.

Authors:  Margaret M Parker; Sharon M Lutz; Brian D Hobbs; Robert Busch; MerryLynn N McDonald; Peter J Castaldi; Terri H Beaty; John E Hokanson; Edwin K Silverman; Michael H Cho
Journal:  Genet Epidemiol       Date:  2019-02-11       Impact factor: 2.135

Review 10.  The role of early LDL lowering to prevent the onset of atherosclerotic disease.

Authors:  Brian A Ference; Nitin Mahajan
Journal:  Curr Atheroscler Rep       Date:  2013-04       Impact factor: 5.113

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.